• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有众多序列差异的同种异体MHC I类分子不会引发CTL反应。

Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response.

作者信息

Heemskerk Martin B A, Roelen Dave L, Dankers Marlies K A, van Rood Jon J, Claas Frans H J, Doxiadis Ilias I N, Oudshoorn Machteld

机构信息

Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Hum Immunol. 2005 Sep;66(9):969-76. doi: 10.1016/j.humimm.2005.06.007. Epub 2005 Oct 10.

DOI:10.1016/j.humimm.2005.06.007
PMID:16360836
Abstract

CD8+ T cell-mediated alloreactivity is generally believed to involve recognition of the alpha1/alpha2 domains of donor-type class I MHC molecules as well as the peptides they bind. Using the CTLp assay outcome as a parameter for the induction of alloreactivity, we have retrospectively surveyed 80 haematopoietic stem cell donor/patient pairs that feature a range of allelic differences at single HLA-A, -B, and -C loci in an attempt to probe the predictive value of such mismatches. In contrast to the expectation that greater degree of allelic disparity would lead to more alloreactivity, we found that in a substantial number of cases, class I MHC molecules with numerous sequence differences did not elicit an allogeneic CTL response. We propose that in generating a T cell repertoire with a sufficiently narrow responsive for self-MHC, positive thymic selection limits the capacity to recognize allogeneic MHC molecules whose structure and sequence have diverged extensively. These findings are important for donor and patient MHC matching strategies and our understanding of T cell-MHC interaction after haematopoietic stem cell transplantation.

摘要

一般认为,CD8 + T细胞介导的同种异体反应性涉及对供体I类MHC分子的α1/α2结构域及其所结合肽段的识别。以细胞毒性T淋巴细胞前体(CTLp)检测结果作为诱导同种异体反应性的参数,我们回顾性调查了80对造血干细胞供体/受者,这些供体/受者在单个HLA - A、- B和 - C位点存在一系列等位基因差异,旨在探究此类错配的预测价值。与等位基因差异程度越大将导致更多同种异体反应性的预期相反,我们发现,在大量病例中,具有众多序列差异的I类MHC分子并未引发同种异体CTL反应。我们提出,在产生对自身MHC反应性足够狭窄的T细胞库时,阳性胸腺选择限制了识别结构和序列已广泛分化的同种异体MHC分子的能力。这些发现对于供体和受者MHC匹配策略以及我们对造血干细胞移植后T细胞 - MHC相互作用的理解具有重要意义。

相似文献

1
Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response.具有众多序列差异的同种异体MHC I类分子不会引发CTL反应。
Hum Immunol. 2005 Sep;66(9):969-76. doi: 10.1016/j.humimm.2005.06.007. Epub 2005 Oct 10.
2
Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation.高度分化的主要组织相容性复合体I类错配对于造血干细胞移植是可接受的。
Bone Marrow Transplant. 2007 Aug;40(3):193-200. doi: 10.1038/sj.bmt.1705721. Epub 2007 May 28.
3
Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules.MHC Ⅰ类分子α2和α3结构域在自身与非自身MHC分子识别中的重要性。
J Immunol. 1996 Apr 1;156(7):2473-80.
4
A proposed algorithm predictive for cytotoxic T cell alloreactivity.一种预测细胞毒性 T 细胞同种异体反应性的算法。
J Immunol. 2012 Feb 15;188(4):1868-73. doi: 10.4049/jimmunol.1102086. Epub 2012 Jan 18.
5
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
6
Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.供体来源的CD4细胞毒性T细胞识别的同种异体抗原可能参与血液系统恶性肿瘤患者干细胞移植后的选择性移植物抗白血病效应。
Br J Haematol. 2006 Jan;132(1):56-65. doi: 10.1111/j.1365-2141.2005.05843.x.
7
Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.在同种异体移植工程中,使用患者来源的非造血刺激细胞选择性清除同种异体反应性T淋巴细胞。
Transplantation. 2008 Nov 27;86(10):1427-35. doi: 10.1097/TP.0b013e31818810d6.
8
Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome.将细胞毒性T细胞同种异体反应性的体外预测转化为造血干细胞移植结果。
Transpl Immunol. 2014 Mar;30(2-3):59-64. doi: 10.1016/j.trim.2013.08.006. Epub 2014 Jan 17.
9
Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.同种异体MHC基因转移增强了同种异体造血干细胞移植的抗肿瘤活性,而不会加剧移植物抗宿主病。
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2208-15. doi: 10.1158/1078-0432.CCR-05-2657.
10
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self.异基因造血移植与自然杀伤细胞对缺失自我的识别
Immunol Rev. 2006 Dec;214:202-18. doi: 10.1111/j.1600-065X.2006.00455.x.

引用本文的文献

1
Novel Scoring System for Ranking Hematopoietic Stem Cell Transplantation.新型造血干细胞移植评分系统。
Clin Transplant. 2024 Nov;38(11):e15478. doi: 10.1111/ctr.15478.
2
HLA evolutionary divergence (HED) informs the effect of HLA-B mismatch on outcomes after haploidentical transplantation.HLA 进化分歧(HED)提示了 HLA-B 错配对单倍体相合移植后结局的影响。
Bone Marrow Transplant. 2024 Oct;59(10):1433-1439. doi: 10.1038/s41409-024-02341-z. Epub 2024 Jul 31.
3
Permissible HLA mismatches in 9/10 unrelated donor pediatric stem cell transplants using HLA-EMMA: an EBMT Inborn Errors Working Party study.
使用 HLA-EMMA 在 9/10 个无关供体儿科干细胞移植中允许的 HLA 错配:EBMT 先天错误工作组研究。
Blood Adv. 2024 Sep 24;8(18):4767-4777. doi: 10.1182/bloodadvances.2024012945.
4
HLA3D: an integrated structure-based computational toolkit for immunotherapy.HLA3D:一个集成基于结构的免疫疗法计算工具包。
Brief Bioinform. 2022 May 13;23(3). doi: 10.1093/bib/bbac076.
5
Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study.来自2个HLA单倍型不匹配的家庭供体的异基因造血干细胞移植治疗移植后复发:一项前瞻性I/II期研究。
Bone Marrow Transplant. 2021 Jan;56(1):70-83. doi: 10.1038/s41409-020-0980-8. Epub 2020 Jun 20.
6
The Dual Role of HLA-C in Tolerance and Immunity at the Maternal-Fetal Interface.HLA-C 在母体-胎儿界面的耐受和免疫中的双重作用。
Front Immunol. 2019 Dec 9;10:2730. doi: 10.3389/fimmu.2019.02730. eCollection 2019.
7
Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations.预测性间接识别 HLA 表位在异基因造血细胞移植中的探索性研究。
Front Immunol. 2019 Apr 24;10:880. doi: 10.3389/fimmu.2019.00880. eCollection 2019.
8
Blockade of CTLA-4 and Tim-3 pathways induces fetal loss with altered cytokine profiles by decidual CD4T cells.阻断 CTLA-4 和 Tim-3 通路会导致蜕膜 CD4T 细胞改变细胞因子谱,从而引起胎儿丢失。
Cell Death Dis. 2019 Jan 8;10(1):15. doi: 10.1038/s41419-018-1251-0.
9
In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.通过功能距离预测无关造血干细胞移植中 HLA-DPB1 不合的非允许性
Blood Adv. 2018 Jul 24;2(14):1773-1783. doi: 10.1182/bloodadvances.2018019620.
10
Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing.通过深度测序评估针对结构相似或不相似 HLA-DP 抗原的同种反应性 T 细胞受体多样性。
Front Immunol. 2018 Feb 19;9:280. doi: 10.3389/fimmu.2018.00280. eCollection 2018.